Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Peptides containing saccharide radicals – e.g. – bleomycins – etc.
Reexamination Certificate
2006-02-24
2009-12-15
Tsang, Cecilia (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Peptides containing saccharide radicals, e.g., bleomycins, etc.
Reexamination Certificate
active
07632918
ABSTRACT:
Semi-synthetic glycopeptides having antibacterial activity are based on modifications of the eremomycin, A82846B, vancomycin, teicoplanin, and A-40,926 scaffolds, in particular, acylation of the sugar moieties on these scaffolds with certain acyl groups; and/or conversion of an acid moiety on the macrocyclic ring of these scaffolds to certain substituted amides; or having a combination of an alkylation modification of the amino substituent on the amino-substituted sugar moiety on these scaffolds with certain alkyl groups or acylation modification of the amino substituent on the amino-substituted sugar moiety on this scaffold with certain alkyl groups, and conversion of the acid moiety on the macrocyclic ring of this scaffolds to certain substituted amides. Also provided are methods for the synthesis of the compounds, pharmaceutical compositions containing the compounds, and methods of use of the compounds for the treatment and/or prophylaxis of diseases, especially bacterial infections.
REFERENCES:
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 5488131 (1996-01-01), Myers
patent: 5500410 (1996-03-01), Malabarba et al.
patent: 5521155 (1996-05-01), Malabarba et al.
patent: 5840684 (1998-11-01), Cooper et al.
patent: 5977062 (1999-11-01), Cooper et al.
patent: 6841661 (2005-01-01), Kim et al.
patent: 7273845 (2007-09-01), Zhao et al.
patent: 7368422 (2008-05-01), Lei et al.
patent: 7348309 (2008-07-01), Thorson
patent: 2003/0008812 (2003-01-01), Christensen et al.
patent: 2004/0136947 (2004-07-01), Zhao et al.
patent: 2004/0259228 (2004-12-01), Thorson
patent: 2006/0276623 (2006-12-01), Chu et al.
patent: 2007/0021328 (2007-01-01), Lei et al.
patent: 0276740 (1988-08-01), None
patent: 0365319 (1990-04-01), None
patent: 036531 (1995-08-01), None
patent: 0667353 (1995-08-01), None
patent: WO00/59528 (2000-10-01), None
patent: WO 00/59528 (2000-10-01), None
patent: WO00/69893 (2000-11-01), None
patent: WO01/58933 (2001-08-01), None
patent: WO01/81372 (2001-11-01), None
patent: WO 2004/019970 (2004-03-01), None
patent: WO2004/019970 (2004-11-01), None
patent: WO2006/093933 (2006-09-01), None
patent: WO2006/094082 (2006-09-01), None
Idogaki et al, “Preparation of (R)- and (S)-4-chloro-3-acetoxybutyronitrile using microbial resolution,” Tetrahedron: Asymmetry vol. 12, Issue 3, Mar. 5, 2001, pp. 369-373.
L3 Answer 6 of 7 Hcaplus Copyright 2009 ACS on STN atached as pdf file STN—Search—Reference.pdf pp. 1-4.
PCT/US06/07049, International Search Report mailed Mar. 28, 2007.
PCT/US06/07049, Written Opinion mailed Mar. 28, 2007.
Berge et al., Journal of Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, pp. 1-19.
Miroshnikova et al., “Structure-Activity Relationships in the Series of Eremomycin Carboxamides”, The Journal Antibiotics, vol. 53, No. 3, Mar. 2000, pp. 286-291.
Pavlov et al., “A New Type of Chemical Modification of Glycopeptides Antibiotics: Aminomethylated Derivatives of Eremomycin and Their Antibacterial Activity”, The Journal of Antibiotics, vol. 50, No. 6, Jun. 1997, pp. 509-513.
Pavlov et al., “Carboxamides and Hydrazide of Glycopeptide Antibiotic Eremomycin Synthesis and Antibacterial activity”, The Journal of Antibiotics, vol. 39, No. 2, Feb. 1996, pp. 194-198.
Feliu. L. et al.,Cyclic Peptides Containing Biaryl and Biaryl Ether Linkages, International Journal of Peptide Research and Therapeutics, vol. 11, No. 1, Mar. 2005, pp. 53-97.
Jia, Y. et al.,Identification of synthetic compounds active against VRE: the role of the lapidated aminoglucose and the structure of glycopeptide binding pocket, Bioorganic&Medicinal Chemistry Letters, 15 (2005) 4594-4599.
Malabarba, A. et al.,Structural Modifications of Glycopeptide Antibiotics, Medicinal Research Reviews, vol. 17, No. 1, (1997) 69-137.
Nagarajan, R. et al.,Synthesis and Antibacterial Activity of N-ACYL Vancomycins, The Journal of Antibiotics, Oct. 1988, pp. 1430-1438.
U.S. Appl. No. 11/361,852, entitledSemi-Synthetic Desmethyl-Vancomycin-Based Glycopeptides with Antibiotic Activity, Chu et al., filed Feb. 24, 2006.
International patent application No. PCT/US06/07337, International Search Report dated Nov. 20, 2006.
International patent application No. PCT/US06/07337, Written Opinion dated Nov. 20, 2006.
U.S Office Action, for U.S. Appl. No. 11/361,682, mailed Jul. 11, 2008.
L. Boeck et al. J. Antibiotics (1984) 37(5), pp. 446-453.
H.-K. Han. AAPS Pharmsci. (2000) 2(1), article 6, pp. 1-11.
S.R. Vippagunta, et al. Adv. Drug Delivery Rev. (2001) 48, pp. 3-26.
P. Ettmayer et al., J. Med. Chem (2004) 47(10), pp. 2393-2404.
B. Testa. Biochem. Pharm (2004) 68, pp. 2097-2106.
J. March Organic Chemistry, 3rd Ed. (1985), pp. 66-70, 82-119 and 1024-1026.
Majumdar S. et al., Expert Opin. Drug Delivery (2006) 39(4), pp. 511-527.
U.S. Office Action for U.S. Appl. No. 10/525,784, mailed Jul. 25, 2008.
International Search Rpt for PCT/US06/07021, mailed Nov. 28, 2006.
International Written Opinion for PCT/US06/0721, mailed Nov. 28, 2006.
Notice of Allowance for U.S. Appl. No. 11/361,311, mailed Oct. 30, 2007.
U.S. Office Action for U.S. Appl. No. 11/361,311, mailed Mar. 22, 2007.
U.S. Final Office Action for U.S. Appl. No. 11/361,311, mailed Sep. 10, 2007.
International Search Rpt for PCT/2004/019970, mailed Jul. 22, 2004.
International Preliminary Examination Report for PCT/WO2004/019970, mailed Nov. 12, 2004.
Georgiou, Niki A et al: “The chemotherapeutic agent bleomycin in a two-drug combination with zidovudine, ritonavir or indinavir synergistically inhibits HIV Type-1 replication in peripheral blood lymphocytes”, International Journal of Antimicrobial agents, vol. 18, No. 6 Dec. 2001, pp. 513-518.
Singh S. B. et al: “The complestatins as HIV-1 integrease inhibitors. Efficient isolation; structure elucidation, and inhibitory activities of isocomplestatin, chloropeptin I, new complestatins, A and B, and acid-hydrolysis products of chloropeptin I.” Journal of Natural Products. US, Jul. 2001, vol. 64, No. 7, Jul. 2001, pp. 874-882.
Allen Norris E. et al.: “Hexapeptide derivatives of glycopeptide antibiotics: Tools for mechanism of action studies” Antimicrobial Agents and Chemotherapy, vol. 46, No. 8, Aug. 2002, pp. 2344-2348.
Borghi A. et al.: “Microbial De-Mannosylation and Mannosylation of Teicoplanin Derivatives” Journal of Antibiotics, Japan Antibiotics Research Association. Tokyo, JP, vol. 44, No. 12, Dec. 1991, pp. 1444-1451.
Malabarba A Nicas TI Ciabatti R: “Glycopeptide resistance in multiple antibiotic-resistant Gram-positive bacteria: a current challenge for novel semi-synthetic glycopeptide derivatives” European Journal of Medicinal Chemistry, Editions Scientifique Elsevier, Paris, FR, vol. 32, No. 6, Jun. 1, 1997, pp. 459-478.
Malabarba A. et al.: “Teicoplanin, Antibiotics from Actinoplanes Teichomyceticus Nov. SP. VII. Preparation and NMR Characteristics of the Aglycone of Teicoplanin” Journal of Antibiotics, Japan Antibiotics Research Association. Tokyo, JP, vol. 39, No. 10, Oct. 1986, pp. 1430-1442.
Chu Daniel
Olsufyeva Eugenia N.
Preobrazhenskaya Maria N.
Printsevskaya Svetlana S.
Heard Thomas S
Novartis Vaccines and Diagnostics Inc.
Tsang Cecilia
Weaver Austin Villeneuve & Sampson LLP
LandOfFree
Semi-synthetic glycopeptides with antibiotic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Semi-synthetic glycopeptides with antibiotic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Semi-synthetic glycopeptides with antibiotic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4057289